A dose-finding and pharmacokinetic study of the matrix metalloproteinase inhibitor MMI270 (previously termed CGS27023A) with 5-FU and folinic acid


Autoria(s): Eatock, Martin; Cassidy, J.; Johnson, J.; Morrison, R.; Devlin, M.; Blackey, R.; Owen, S.; Choi, L.; Twelves, C.
Data(s)

01/01/2005

Identificador

http://pure.qub.ac.uk/portal/en/publications/a-dosefinding-and-pharmacokinetic-study-of-the-matrix-metalloproteinase-inhibitor-mmi270-previously-termed-cgs27023a-with-5fu-and-folinic-acid(f228a0c9-3fb6-4e40-a4d4-b0d8a42c6bf6).html

http://dx.doi.org/10.1007/s00280-004-0856-4

http://www.scopus.com/inward/record.url?scp=11244354290&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Eatock , M , Cassidy , J , Johnson , J , Morrison , R , Devlin , M , Blackey , R , Owen , S , Choi , L & Twelves , C 2005 , ' A dose-finding and pharmacokinetic study of the matrix metalloproteinase inhibitor MMI270 (previously termed CGS27023A) with 5-FU and folinic acid ' Cancer Chemotherapy and Pharmacology , vol 55(1) , no. 1 , pp. 39-46 . DOI: 10.1007/s00280-004-0856-4

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/1300/1306 #Cancer Research #/dk/atira/pure/subjectarea/asjc/3000/3004 #Pharmacology #/dk/atira/pure/subjectarea/asjc/2700/2730 #Oncology
Tipo

article